Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden error instead of the study record content, replacing the expected information with an error screen and navigation footer.
    Difference
    21%
    Check dated 2026-09-23T00:00:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A prompt to locate contact information was added to the page, improving accessibility for inquiries about the study. The page revision was updated to v3.7.0, reflecting an updated version of the content.
    Difference
    0.1%
    Check dated 2026-09-16T00:02:00.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.6, replacing v3.6.5, indicating a maintenance release of the site. It reflects an update to the site's version tag rather than any changes to study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T19:33:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor backend/version update and does not change the study information or how the page is used.
    Difference
    0.0%
    Check dated 2026-08-11T18:36:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.6.3 to v3.6.4, signaling a platform update rather than any modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T12:36:17.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Publications section added with a PubMed-derived citation and a note about automatic population from PubMed. The change provides direct literature references and clarifies data provenance for the study record.
    Difference
    0.2%
    Check dated 2026-07-14T08:51:22.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.